ICN PHARMACEUTICALS INC /DE/
DEFC14A, 1994-01-24
PHARMACEUTICAL PREPARATIONS
Previous: WHITMAN CORP, 424B5, 1994-01-24
Next: MERRILL LYNCH & CO INC, 424B5, 1994-01-24



<PAGE>

                            SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
 
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
 
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Definitive Proxy Statement
[X] Definitive Additional Materials
[ ] Soliciting Material Pursuant to SS240.14a-11(c) or SS240.14a-12
 
                           ICN PHARMACEUTICALS, INC.
         ----------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)
 
                                  RAFI M. KHAN
         ----------------------------------------------------------
                   (Name of Person(s) Filing Proxy Statement)
 
Payment of Filing Fee (Check the appropriate box):
[ ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-6(i)(2).
[ ] $500 per each party to the controversy pursuant to Exchange Act Rule
    14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
    1) Title of each class of securities to which transaction applies:
       -------------------------------------------------------------------------
 
    2) Aggregate number of securities to which transaction applies:
       -------------------------------------------------------------------------
 
    3) Per unit price or other underlying value of transaction computed pursuant
       to Exchange Act Rule 0-11.(1)
       -------------------------------------------------------------------------
 
    4) Proposed maximum aggregate value of transaction:
       -------------------------------------------------------------------------
 
(1) Set  forth the amount on which the filing fee is calculated and state how it
    was determined.
 
[ ] Check  box if any part of the fee is offset as provided by Exchange Act Rule
    0-11(a)(2) and identify  the filing for  which the offsetting  fee was  paid
    previously.  Identify the previous filing  by registration statement number,
    or the Form or Schedule and the date of its filing.
 
    1) Amount Previously Paid:
       -------------------------------------------------------------------------
 
    2) Form, Schedule or Registration Statement No.:
       -------------------------------------------------------------------------
 
    3) Filing Party:
       -------------------------------------------------------------------------
 
    4) Date Filed:
       -------------------------------------------------------------------------
 
<PAGE>
                                January 21, 1994
 
VIA FACSIMILE (303) 930-6451

Glenn Payne, Esq.
Legal Counsel
INVESCO Funds Group
7800 E. Union Avenue
Suite 800
Denver, CO 80201
 
Dear Mr. Payne:
 
     I am writing  this letter  to ensure  that there  are no  misunderstandings
between INVESCO and me as a result of the misleading articles about me that have
appeared in the news media over the past few weeks. I want you to know that I am
seriously  considering  bringing a  legal  action against  at  least one  of the
newspapers that has been issuing the misstatements.
 
     I strongly contend and want on the record that throughout my dealings  with
the  various Invesco portfolio managers, my behavior was at all times exemplary,
and I am confident  that both current and  former portfolio managers of  Invesco
would confirm this. In addition, all the Invesco portfolio managers I have dealt
with  have at all times acted professionally in their dealings with me. In fact,
my stock selections have made INVESCO many hundreds of millions of dollars.
 
     If you have absolutely  any questions or doubts  on these matters, I  would
ask  you to direct them to me immediately.  I would also be pleased to visit you
at your offices in Denver.
 
     I look forward to hearing from you.
 
                                          Very truly yours,
                                          Rafi M. Khan
 
89151
 
<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission